News
UTHR ▲ +0.0% - United Therapeutics Corporation
UTHR ▲ +0.0% - United Therapeutics Corporation
$UTHR United Therapeutics Announces FDA Clearance to Proceed with Clinical Trial for Treprostinil-Iloprost SMI in Pulmonary Arterial Hypertension
28-OCT-2026 07:01 AM ET
Share this post
More filings for $UTHR
UTHR ▼ -0.1% - United Therapeutics CorporationOct 19, 2026UTHR ▲ +1.5% - United Therapeutics CorporationOct 1, 2026UTHR ▼ -1.9% - United Therapeutics CorporationSep 24, 2026UTHR ▲ +1.2% - United Therapeutics CorporationSep 8, 2026UTHR - United Therapeutics Corporation - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026UTHR - United Therapeutics Corporation - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 13, 2026
View full $UTHR filing history →💬 Comments
Loading comments…
Leave a comment